Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.

Other borderline significant parameters included the absence ATG in conditioning (HR: 1.52; 95% CI: 1–2.3; p = 0.049), patient CMV seropositive status (HR: 1.41; 95% CI: 1–2; p = 0.041), and HLA-mismatched unrelated donor transplant (HR: 1.68; 95% CI: 1–2.8; p = 0.044) ( Supplementary Tables S5 and S6, Supplementary Figure S9 ).

also in 1,379 other papers